Gabapentin
- Product NDC
- 58657-721
- 11-digit product format
- 586570721
- Labeler code
- 58657
- Product ID
- 58657-721_edb5dd4a-354d-fb9c-e053-2995a90acb47
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Method Pharmaceuticals, LLC
- Application
- ANDA207099
- Marketing category
- ANDA
- Marketing start
- 2017-03-24
- Marketing end
- 2022-12-31
- Substance
- GABAPENTIN
- Active strength
- 300 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 58657-721-01 | 58657072101 | 100 CAPSULE in 1 BOTTLE (58657-721-01) | 100 capsule | 2017-03-24 | 0000-00-00 | No | No | Current |
| 58657-721-10 | 58657072110 | 1000 CAPSULE in 1 BOTTLE (58657-721-10) | 1000 capsule | 2017-03-24 | 0000-00-00 | No | No | Current |
| 58657-721-50 | 58657072150 | 500 CAPSULE in 1 BOTTLE (58657-721-50) | 500 capsule | 2017-03-24 | 0000-00-00 | No | No | Current |